HEADER CALCIUM-BINDING PROTEIN 10-MAR-16 5FYX TITLE CRYSTAL STRUCTURE OF DROSOPHILA NCS-1 BOUND TO PENOTHIAZINE FD16 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FREQUENIN 2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DROSOPHILA MELANOGASTER; SOURCE 3 ORGANISM_COMMON: FRUIT FLY; SOURCE 4 ORGANISM_TAXID: 7227; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PETDUET-1 KEYWDS CALCIUM SENSOR, CALCIUM-BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.MARTINEZ-GONZALEZ,A.CHAVES-SANJUAN,L.INFANTES,M.J.SANCHEZ-BARRENA REVDAT 4 10-JAN-24 5FYX 1 REMARK REVDAT 3 27-DEC-17 5FYX 1 TITLE REVDAT 2 01-MAR-17 5FYX 1 JRNL REVDAT 1 25-JAN-17 5FYX 0 JRNL AUTH A.MANSILLA,A.CHAVES-SANJUAN,N.E.CAMPILLO,O.SEMELIDOU, JRNL AUTH 2 L.MARTINEZ-GONZALEZ,L.INFANTES,J.M.GONZALEZ-RUBIO,C.GIL, JRNL AUTH 3 S.CONDE,E.M.SKOULAKIS,A.FERRUS,A.MARTINEZ, JRNL AUTH 4 M.J.SANCHEZ-BARRENA JRNL TITL INTERFERENCE OF THE COMPLEX BETWEEN NCS-1 AND RIC8A WITH JRNL TITL 2 PHENOTHIAZINES REGULATES SYNAPTIC FUNCTION AND IS AN JRNL TITL 3 APPROACH FOR FRAGILE X SYNDROME. JRNL REF PROC. NATL. ACAD. SCI. V. 114 E999 2017 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 28119500 JRNL DOI 10.1073/PNAS.1611089114 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.70 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 20464 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1842 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.7099 - 4.2314 1.00 2858 120 0.1795 0.1971 REMARK 3 2 4.2314 - 3.3589 1.00 2796 174 0.1816 0.2071 REMARK 3 3 3.3589 - 2.9344 1.00 2885 132 0.2217 0.2626 REMARK 3 4 2.9344 - 2.6662 0.99 2857 84 0.2560 0.2722 REMARK 3 5 2.6662 - 2.4751 1.00 2838 128 0.2464 0.2676 REMARK 3 6 2.4751 - 2.3292 0.99 2787 172 0.2682 0.2803 REMARK 3 7 2.3292 - 2.2125 0.99 2812 167 0.2933 0.3180 REMARK 3 8 2.2125 - 2.1162 0.99 2797 142 0.2938 0.3761 REMARK 3 9 2.1162 - 2.0347 0.99 2795 152 0.3283 0.2879 REMARK 3 10 2.0347 - 1.9645 0.99 2762 183 0.3569 0.3787 REMARK 3 11 1.9645 - 1.9031 0.99 2798 140 0.4057 0.4605 REMARK 3 12 1.9031 - 1.8487 0.98 2822 122 0.4313 0.5172 REMARK 3 13 1.8487 - 1.8000 0.99 2796 126 0.4704 0.5936 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.900 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.74 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 1537 REMARK 3 ANGLE : 0.870 2077 REMARK 3 CHIRALITY : 0.043 212 REMARK 3 PLANARITY : 0.004 264 REMARK 3 DIHEDRAL : 18.109 607 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5FYX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1290066396. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979236 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20513 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 44.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4BY4 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 54% W/V MPD, 0.1M TRIS PH 7.3 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.02850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.71250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.49850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.71250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.02850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.49850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 LYS A 3 REMARK 465 LYS A 4 REMARK 465 ASN A 5 REMARK 465 SER A 6 REMARK 465 GLY A 133 REMARK 465 GLN A 134 REMARK 465 GLN A 135 REMARK 465 PRO A 136 REMARK 465 GLN A 137 REMARK 465 THR A 138 REMARK 465 GLU A 139 REMARK 465 ASP A 140 REMARK 465 GLU A 141 REMARK 465 ASN A 142 REMARK 465 GLY A 186 REMARK 465 ASP A 187 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 169 O HOH A 2058 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP A 19 NH1 ARG A 162 2554 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 58 -70.92 -50.55 REMARK 500 LEU A 184 32.87 -141.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1186 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1188 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1189 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1190 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1191 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1192 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1193 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1194 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FD6 A 1195 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5G08 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRQ BOUND TO A LIGAND REMARK 999 REMARK 999 SEQUENCE REMARK 999 I178M MUTATION DBREF 5FYX A 1 187 UNP Q9VWX8 Q9VWX8_DROME 1 187 SEQADV 5FYX MET A 178 UNP Q9VWX8 ILE 178 ENGINEERED MUTATION SEQRES 1 A 187 MET GLY LYS LYS ASN SER LYS LEU LYS GLN ASP THR ILE SEQRES 2 A 187 ASP ARG LEU THR THR ASP THR TYR PHE THR GLU LYS GLU SEQRES 3 A 187 ILE ARG GLN TRP HIS LYS GLY PHE LEU LYS ASP CYS PRO SEQRES 4 A 187 ASN GLY LEU LEU THR GLU GLN GLY PHE ILE LYS ILE TYR SEQRES 5 A 187 LYS GLN PHE PHE PRO ASP GLY ASP PRO SER LYS PHE ALA SEQRES 6 A 187 SER LEU VAL PHE ARG VAL PHE ASP GLU ASN ASN ASP GLY SEQRES 7 A 187 ALA ILE GLU PHE GLU GLU PHE ILE ARG ALA LEU SER ILE SEQRES 8 A 187 THR SER ARG GLY ASN LEU ASP GLU LYS LEU HIS TRP ALA SEQRES 9 A 187 PHE ARG LEU TYR ASP VAL ASP ASN ASP GLY TYR ILE THR SEQRES 10 A 187 ARG GLU GLU MET TYR ASN ILE VAL ASP ALA ILE TYR GLN SEQRES 11 A 187 MET VAL GLY GLN GLN PRO GLN THR GLU ASP GLU ASN THR SEQRES 12 A 187 PRO GLN LYS ARG VAL ASP LYS ILE PHE ASP GLN MET ASP SEQRES 13 A 187 LYS ASN HIS ASP ASP ARG LEU THR LEU GLU GLU PHE ARG SEQRES 14 A 187 GLU GLY SER LYS ALA ASP PRO ARG MET VAL GLN ALA LEU SEQRES 15 A 187 SER LEU GLY GLY ASP HET CA A1186 1 HET CA A1187 1 HET CA A1188 1 HET MPD A1189 8 HET MPD A1190 8 HET MPD A1191 8 HET MPD A1192 8 HET MPD A1193 8 HET MPD A1194 8 HET FD6 A1195 25 HETNAM CA CALCIUM ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM FD6 N-[2-(2-CHLORANYLPHENOTHIAZIN-10-YL)ETHYL]-4-METHYL- HETNAM 2 FD6 PIPERAZIN-1-AMINE HETSYN FD6 FD16 FORMUL 2 CA 3(CA 2+) FORMUL 5 MPD 6(C6 H14 O2) FORMUL 11 FD6 C19 H23 CL N4 S FORMUL 12 HOH *82(H2 O) HELIX 1 1 LYS A 9 THR A 20 1 12 HELIX 2 2 THR A 23 CYS A 38 1 16 HELIX 3 3 GLU A 45 GLN A 54 1 10 HELIX 4 4 PRO A 61 ASP A 73 1 13 HELIX 5 5 PHE A 82 GLY A 95 1 14 HELIX 6 6 ASN A 96 ASP A 109 1 14 HELIX 7 7 THR A 117 VAL A 132 1 16 HELIX 8 8 THR A 143 ASP A 156 1 14 HELIX 9 9 THR A 164 LYS A 173 1 10 HELIX 10 10 PRO A 176 ALA A 181 1 6 SHEET 1 AA 2 LEU A 42 THR A 44 0 SHEET 2 AA 2 ALA A 79 GLU A 81 -1 O ILE A 80 N LEU A 43 SITE 1 AC1 6 ASP A 73 ASN A 75 ASP A 77 ALA A 79 SITE 2 AC1 6 GLU A 84 HOH A2050 SITE 1 AC2 6 ASP A 156 ASN A 158 ASP A 160 ARG A 162 SITE 2 AC2 6 GLU A 167 HOH A2073 SITE 1 AC3 6 ASP A 109 ASP A 111 ASP A 113 TYR A 115 SITE 2 AC3 6 GLU A 120 HOH A2063 SITE 1 AC4 3 GLY A 33 ASP A 37 FD6 A1195 SITE 1 AC5 5 GLU A 26 GLU A 81 ARG A 94 HOH A2020 SITE 2 AC5 5 HOH A2021 SITE 1 AC6 4 ASP A 37 GLY A 47 LYS A 50 ILE A 51 SITE 1 AC7 6 ASP A 19 TYR A 21 ILE A 91 GLU A 99 SITE 2 AC7 6 HOH A2014 HOH A2015 SITE 1 AC8 2 GLN A 29 TRP A 30 SITE 1 AC9 3 GLU A 24 LYS A 25 ASP A 77 SITE 1 BC1 11 ILE A 51 TYR A 52 PHE A 64 PHE A 72 SITE 2 BC1 11 PHE A 85 THR A 92 TRP A 103 LEU A 107 SITE 3 BC1 11 LEU A 182 MPD A1189 HOH A2055 CRYST1 54.057 62.997 63.425 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018499 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015874 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015767 0.00000